[{"NetIncomeLoss_1_Q3_USD":-32832000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":40187173.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":7570000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-28000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":113742000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-2741000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1196000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q3_shares":155000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-78000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-12000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q3_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":39971766.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":540000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":5056288.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":215000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1587000.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"CommonStockSharesIssued_0_Q3_shares":40472435.0,"Assets_0_Q3_USD":143195000.0,"ShareBasedCompensation_3_Q3_USD":7799000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":5123000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":25.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"AssetsCurrent_0_Q3_USD":133209000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":11636000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":30155000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":6.81,"ResearchAndDevelopmentExpense_3_Q3_USD":69686000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":21005000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":16.5,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":4900000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-177000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":437000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-191000.0,"CommonStockValue_0_Q3_USD":4000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":-1939000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":279000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":62000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":585000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q3_USD":3133000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q3_USD":0.0,"OtherAssetsCurrent_0_Q3_USD":1942000.0,"PaymentsToFundLongtermLoansToRelatedParties_3_Q3_USD":2610000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-99482000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-32844000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1800000.0,"OtherAssetsNoncurrent_0_Q3_USD":2975000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":131267000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2517000.0,"Liabilities_0_Q3_USD":26683000.0,"OperatingLeaseLiability_0_Q3_USD":4404000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":20.72,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-2000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":23.72,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":64000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-32800000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-12000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-73536000.0,"DefinedContributionPlanEmployerMatchingContributionPercent_3_Q3_pure":0.0,"DefinedContributionPlanEmployerMatchingContributionPercent_1_Q3_pure":0.0,"ResidualValueOfLeasedAsset_0_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2168000.0,"LiabilitiesCurrent_0_Q3_USD":19777000.0,"AccountsPayableCurrent_0_Q3_USD":10320000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":131267000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":585000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-99400000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":335000.0,"AdditionalPaidInCapital_0_Q3_USD":381803000.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_3_Q3_USD":7376000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":83694.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"OperatingLeasePayments_3_Q3_USD":594000.0,"OperatingLeasePayments_1_Q3_USD":201000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"DividendsCommonStock_3_Q3_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":91617000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1888000.0,"NetIncomeLoss_3_Q3_USD":-99404000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.076,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-75869000.0,"CurrentIncomeTaxExpenseBenefit_1_Q3_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-265267000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"OperatingIncomeLoss_3_Q3_USD":-99841000.0,"OperatingIncomeLoss_1_Q3_USD":-32641000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":35.98,"PreferredStockValue_0_Q3_USD":null,"DeferredIncomeTaxExpenseBenefit_1_Q3_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":6.99,"OperatingLeaseCost_3_Q3_USD":680000.0,"OperatingLeaseCost_1_Q3_USD":330000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":143195000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":89667.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1887000.0,"OperatingExpenses_3_Q3_USD":99841000.0,"OperatingExpenses_1_Q3_USD":32641000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":2679000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.49,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.82,"ProfitLoss_3_Q3_USD":-99404000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1923000.0,"StockholdersEquity_0_Q3_USD":116512000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":131000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":5028512.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2900840.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":496000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":541000.0,"Ticker":"YMAB","CIK":"1722964","name":"Y-MABS THERAPEUTICS, INC.","OfficialName":"Y-mAbs Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"556910423.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]